Literature DB >> 21342735

Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents.

Jing Chen1, Tao Liu, Rui Wu, Jianshu Lou, Xiaowu Dong, Qiaojun He, Bo Yang, Yongzhou Hu.   

Abstract

A series of novel γ-carboline ketones were designed, synthesized and evaluated for their cytotoxic activity in vitro against six human cancer cell lines (A549, SGC, HCT116, MCF-7, K562 and K562R). Biological evaluation revealed that almost all of the new compounds displayed moderate to potent cytotoxic activities against the tested cells. Among them, seven of the fourteen new compounds show more potent cytotoxic activities against K562R cell line than that of the positive control, taxol. Primary mechanism research on the most potent compound 6f indicated that it was a potent tubulin polymerization inhibitor, with IC(50) value of 4.3 μM, equivalent to that of CA-4, and arresting cell cycle in G(2)/M phase.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342735     DOI: 10.1016/j.ejmech.2011.01.057

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Access to pyrrolo-pyridines by gold-catalyzed hydroarylation of pyrroles tethered to terminal alkynes.

Authors:  Elena Borsini; Gianluigi Broggini; Andrea Fasana; Chiara Baldassarri; Angelo M Manzo; Alcide D Perboni
Journal:  Beilstein J Org Chem       Date:  2011-10-26       Impact factor: 2.883

2.  Mild and efficient Winterfeldt oxidation of 1,2,3,4-tetrahydro-γ-carbolines for the synthesis of dihydropyrrolo[3,2-b]-quinolones and pyrrolo[3,2-b]quinolones.

Authors:  Rong Sheng; Jiangwei Zhu; Yongzhou Hu
Journal:  Molecules       Date:  2012-01-30       Impact factor: 4.411

3.  Design, synthesis and biological evaluation of a series of new resveratrol analogues as potential anti-cancer agents.

Authors:  Lifang Yang; Xuemei Qin; Hongcun Liu; Yanye Wei; Hailiang Zhu; Mingguo Jiang
Journal:  R Soc Open Sci       Date:  2019-09-04       Impact factor: 2.963

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.